World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
24111
World Ranking
1268
National Ranking
84

Richard J. Colonno publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Richard J. Colonno sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 176 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Richard J. Colonno D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard J. Colonno sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Richard J. Colonno is affiliated with Bristol-Myers Squibb in Germany and has contributed extensively to medical research, primarily within the fields of Medicine and Hepatology. Their work spans subfields including Hepatology, Epidemiology, Molecular Biology, Infectious Diseases, and Virology.

Their research focuses on topics related to Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Hepatitis Viruses Studies and Epidemiology, RNA Interference and Gene Delivery, HIV/AIDS drug development and treatment, and HIV Research and Treatment.

Colonno has published in several prominent scientific venues. Frequent publication venues include:

  • Journal of Hepatology
  • Hepatology
  • Antimicrobial Agents and Chemotherapy
  • Journal of Viral Hepatitis
  • Antiviral Research

Notable recent papers authored or co-authored by Colonno include:

  • "Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients" (2020), Hepatology
  • "Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731" (2020), Antimicrobial Agents and Chemotherapy
  • "Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection" (2022), Journal of Hepatology
  • "Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection" (2022), Journal of Hepatology
  • "Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study" (2020), Journal of Hepatology

Colonno has collaborated frequently with several researchers, including:

  • Qi Huang
  • Tuan Nguyen
  • Edward Gane
  • Ran Yan
  • Steven Knox

Best Publications

  • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

    Ting Tsung Chang;Robert G. Gish;Robert De Man;Adrian Gadano

  • Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

    Ching Lung Lai;Daniel Shouval;Anna S. Lok;Ting Tsung Chang

  • Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

    Min Gao;Richard E. Nettles;Makonen Belema;Lawrence B. Snyder

  • Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

    Daniel J. Tenney;Ronald E. Rose;Carl J. Baldick;Kevin A. Pokornowski

  • Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

    D J Tenney;S M Levine;R E Rose;A W Walsh

  • Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.

    Morris Sherman;Cihan Yurdaydin;Jose Sollano;Marcelo Silva

  • A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

    Pin-Fang Lin;Wade Blair;Tao Wang;Timothy Spicer

  • Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

    Robert G. Gish;Anna S. Lok;Ting Tsung Chang;Robert A. de Man

  • Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.

    Richard J. Colonno;Ronald Rose;Carl J. Baldick;Steven Levine

  • Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.

    Jie Wang;Tao Shen;Xiangbo Huang;G. Renuka Kumar

  • Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.

    B Sherry;A G Mosser;R J Colonno;R R Rueckert

  • De Novo Initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase (NS5B) of Hepatitis C Virus

    Guangxiang Luo;Robert K. Hamatake;Danielle M. Mathis;Jason Racela

  • Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.

    Ronald S. Veazey;Per Johan Klasse;Susan M. Schader;Qinxue Hu

  • cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1

    Joanne E. Tomassini;Donald Graham;Corrille M. Dewitt;Donald W. Lineberger

  • Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.

    S F Innaimo;M Seifer;G S Bisacchi;D N Standring

  • A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-refractory Chronic Hepatitis B Patients

    Ting–Tsung Chang;Robert G. Gish;Stephanos J. Hadziyannis;Janusz Cianciara

  • Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

    Daniel J. Tenney;Ronald E. Rose;Carl J. Baldick;Steven M. Levine

  • Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.

    Tao Wang;Zhongxing Zhang;Owen B. Wallace;Milind Deshpande

  • The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

    M Gao;L Matusick-Kumar;W Hurlburt;S F DiTusa

  • BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents

    Brett S. Robinson;Keith A. Riccardi;Yi-fei Gong;Qi Guo

Frequent Co-Authors

Nicholas A. Meanwell
Nicholas A. Meanwell Bristol-Myers Squibb (Germany)
Mark Krystal
Mark Krystal ViiV Healthcare (United Kingdom)
Man-Fung Yuen
Man-Fung Yuen University of Hong Kong
Guangxiang Luo
Guangxiang Luo University of Alabama at Birmingham
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
Robert G. Gish
Robert G. Gish University of Nevada Reno
Amiya K. Banerjee
Amiya K. Banerjee Cleveland Clinic Foundation
Jinlin Hou
Jinlin Hou Southern Medical University
Sang Hoon Ahn
Sang Hoon Ahn Yonsei University
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology offers a strong foundation for various health and science-related careers. Many students explore complementary online programs to broaden their skill sets and improve employability. For those interested in the administrative side of healthcare, pursuing a health information management bachelor degree salary can be a critical consideration when selecting a program. It highlights the financial benefits of this growing field.

If you’re looking for quality programs, the best online health information management degree cahiim accredited guide provides excellent insight into accredited options. Accreditation ensures the program meets professional standards and enhances career prospects.

For students interested in shorter, focused credentials, exploring the medical billing and coding certificate online accelerated programs can be valuable. These certificates offer a fast track into vital healthcare support roles, complementing microbiology knowledge.

Additionally, understanding the variety of online medical degrees available helps prospective students align their microbiology background with broader medical or health sciences careers. Online options increase accessibility and flexibility for continued education.

Best Scientists Citing Richard J. Colonno

Trending Scientists

Recently Published Articles